NKGen Biotech Inc (NASDAQ:NKGN) has a beta value of 0.50 and has seen 2.04 million shares traded in the last trading session. The company, currently valued at $28.36M, closed the last trade at $0.63 per share which meant it lost -$0.14 on the day or -17.93% during that session. The NKGN stock price is -544.44% off its 52-week high price of $4.06 and 68.25% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 8.87 million shares traded. The 3-month trading volume is 1.92 million shares.
NKGen Biotech Inc (NASDAQ:NKGN) trade information
Sporting -17.93% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NKGN stock price touched $0.63 or saw a rise of 30.77%. Year-to-date, NKGen Biotech Inc shares have moved -3.69%, while the 5-day performance has seen it change 47.53%. Over the past 30 days, the shares of NKGen Biotech Inc (NASDAQ:NKGN) have changed 24.21%. Short interest in the company has seen 0.52 million shares shorted with days to cover at 2.3.
NKGen Biotech Inc (NKGN) estimates and forecasts
The company’s shares have lost -29.97% over the past 6 months.
NKGN Dividends
NKGen Biotech Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders
Insiders own 39.40% of the company shares, while shares held by institutions stand at 21.93% with a share float percentage of 36.19%. Investors are also buoyed by the number of investors in a company, with NKGen Biotech Inc having a total of 26.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 0.39% shares in the company for having 174.0 shares of worth $0.11 million while later fund manager owns 67.25 shares of worth $42434.0 as of Nov 30, 2024 , which makes it owner of about 0.15% of company’s outstanding stock.
